Cargando…
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2
Pancreatic cancer has an extremely poor prognosis because of its resistance to conventional therapies. Cancer stem cell (CSC)‐targeted therapy is considered a promising approach for this disease. Epithelial‐mesenchymal transition‐inducing transcription factors (EMT‐TFs) contribute to CSC properties...
Autores principales: | Masuo, Kenji, Chen, Ru, Yogo, Akitada, Sugiyama, Aiko, Fukuda, Akihisa, Masui, Toshihiko, Uemoto, Shinji, Seno, Hiroshi, Takaishi, Shigeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645768/ https://www.ncbi.nlm.nih.gov/pubmed/34628696 http://dx.doi.org/10.1111/cas.15162 |
Ejemplares similares
-
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
por: Watanabe, Sadanori, et al.
Publicado: (2022) -
Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling
por: Yogo, Akitada, et al.
Publicado: (2022) -
Time–frequency analysis of serum with proton nuclear magnetic resonance for diagnosis of pancreatic cancer
por: Sato, Asahi, et al.
Publicado: (2020) -
Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cells
por: Chen, Ru, et al.
Publicado: (2020) -
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity‐modulated radiotherapy for resectable pancreatic cancer: A prospective, open‐label, phase II study
por: Masui, Toshihiko, et al.
Publicado: (2023)